Retatrutide 30mg Reusable Pen Kit
Retatrutide is an investigational once-weekly triple-hormone injection (GLP-1, GIP, and glucagon receptor agonist) showing superior weight loss, with phase 2 trials demonstrating up to 24% body weight loss in 48 weeks. It offers significant metabolic benefits, including improved blood sugar control, up to 80% liver fat reduction, and better blood pressure.
Key Benefits of Retatrutide:
- Significant Weight Loss: Trials showed that at 48 weeks, participants on the highest dose lost an average of 24.2% of their body weight, with some losing over 30%.
- Triple-Action Metabolism Boost: Unlike dual agonists (like Tirzepatide) or GLP-1s, retatrutide targets GIP, GLP-1, and glucagon receptors. The added glucagon receptor agonism increases energy expenditure (calories burned) alongside reducing appetite.
- Substantial Fat Reduction: Studies indicated a significant reduction of up to 80% in liver fat by week 24.
- Improved Metabolic Health: Participants experienced improved glycemic control, lower blood pressure, and improved lipid levels. Over 70% of participants with pre-diabetes returned to normal blood sugar levels.
- Potential Cardiorenal Protection: Phase 2 data suggested improved kidney function markers, specifically a 31.5% reduction in urinary albumin in some participants.
- Reduced Cravings: Participants reported reduced snacking, improved control over hunger, and better eating behavior management. Retatrutide is in phase 3 clinical trials, with potential FDA approval anticipated between late 2026 and 2027.
- Common side effects are generally gastrointestinal—nausea, diarrhea, vomiting, and constipation—which are usually mild-to-moderate and occur during dose increases.
Information:
Retatrutide 30mg Reusable Pen Kit delivers precise dosing in a convenient, easy-to-use format. Each kit includes the reusable pen, the Retatrutide 30mg refill vial, 8 x alcohol swabs & 8 needles. Due to it being a reusable Pen, you only have to purchase the pen once. Afterwards you can purchase the Retatrutide 30mg refill vial. Making the convenience of a pen accessible & affordable for everyone.
Concentration
30mg
Dosage
Starting Dose: 2mg